T1	CHEM 88 98	MITOMICINA
#1	AnnotatorNotes T1	C0002475; mitomycin; Organic Chemical · Antibiotic
T2	PROC 124 135	TRATAMIENTO
#2	AnnotatorNotes T2	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T3	DISO 153 190	TUMOR VESICULA NO MÚSCULO INFILTRANTE
T4	ANAT 171 178	MÚSCULO
#3	AnnotatorNotes T4	C0026845; Muscle Tissue; Tissue
T5	DISO 234 260	Cáncer Vesical Superficial
#4	AnnotatorNotes T5	C1336527; Carcinoma of urinary bladder, superficial; Neoplastic Process
T6	DISO 287 323	Tumor Vesical No Músculo Infiltrante
T7	ANAT 293 300	Vesical
#5	AnnotatorNotes T7	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T8	ANAT 304 311	Músculo
#6	AnnotatorNotes T8	C0026845; Muscle Tissue; Tissue
T9	PROC 373 381	operados
#7	AnnotatorNotes T9	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T10	DISO 385 415	tumor no infiltrante de vejiga
T11	ANAT 409 415	vejiga
#8	AnnotatorNotes T11	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T12	DISO 606 631	tumor músculo infiltrante
T13	ANAT 612 619	músculo
#9	AnnotatorNotes T13	C0026845; Muscle Tissue; Tissue
T14	DISO 639 656	Carcinoma In Situ
#10	AnnotatorNotes T14	C0007099; Carcinoma in Situ; Neoplastic Process | C0851135; In situ cancer; Neoplastic Process
T15	DISO 661 678	Hipersensibilidad
#11	AnnotatorNotes T15	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T16	DISO 681 688	alergia
#12	AnnotatorNotes T16	C1527304; Allergic Reaction; Pathologic Function
T17	CHEM 751 754	BCG
#13	AnnotatorNotes T17	C2698319; Bacillus Calmette-Guerin Antigen; Immunologic Factor
T18	DISO 759 791	Carcinoma de células uroteliales
T19	ANAT 772 791	células uroteliales
T20	ANAT 159 167	VESICULA
#14	AnnotatorNotes T20	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T21	ANAT 807 824	uretra prostática
#15	AnnotatorNotes T21	C0458450; Prostatic Urethra; Body Part, Organ, or Organ Component | C0458455; Entire prostatic urethra; Body Part, Organ, or Organ Component
T22	ANAT 827 851	tracto urinario superior
T23	DISO 869 876	tumores
#16	AnnotatorNotes T23	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T24	DISO 908 940	carcinoma transicional de vejiga
T25	ANAT 934 940	vejiga
#17	AnnotatorNotes T25	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T26	PROC 993 1006	quimioterapia
#18	AnnotatorNotes T26	C0392920; Chemotherapy Regimen; Therapeutic or Preventive Procedure | C3665472; Chemotherapy; Therapeutic or Preventive Procedure
T27	PROC 1053 1067	consentimiento
#19	AnnotatorNotes T27	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T28	CHEM 1173 1202	anticonceptivos no hormonales
T29	DISO 1206 1225	Estenosis de uretra
T30	PROC 1247 1254	sondaje
#20	AnnotatorNotes T30	C0007430; Catheterization; Therapeutic or Preventive Procedure | C0883301; Catheter placement; Therapeutic or Preventive Procedure
T31	PROC 1263 1274	instilación
#21	AnnotatorNotes T31	C0184959; Instillation (procedure); Health Care Activity
T32	PROC 1280 1291	Tratamiento
#22	AnnotatorNotes T32	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T33	CHEM 1350 1353	BCG
#23	AnnotatorNotes T33	C2698319; Bacillus Calmette-Guerin Antigen; Immunologic Factor
T34	ANAT 241 248	Vesical
#24	AnnotatorNotes T34	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T35	CHEM 694 704	mitomicina
#25	AnnotatorNotes T35	C0002475; mitomycin; Organic Chemical · Antibiotic
T36	DISO 725 741	reaccion adversa
#26	AnnotatorNotes T36	C0559546; Adverse reactions; Pathologic Function
T37	ANAT 1219 1225	uretra
#27	AnnotatorNotes T37	C0041967; Urethra; Body Part, Organ, or Organ Component | C1281574; Entire urethra; Body Part, Organ, or Organ Component
T38	CHEM 1296 1312	inmunosupresores
#28	AnnotatorNotes T38	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
T39	PROC 1334 1345	instilación
#29	AnnotatorNotes T39	C0184959; Instillation (procedure); Health Care Activity
T40	PROC 538 562	consentimiento informado
#30	AnnotatorNotes T40	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T41	PROC 66 83	QUIMIOHIPERTERMIA
T42	Date 13 17	2016
T43	Route 99 111	INTRAVESICAL
T44	LIVB 140 148	PACIENTE
#31	AnnotatorNotes T44	C0030705; Patients; Patient or Disabled Group
T47	LIVB 363 372	pacientes
#32	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T49	Age 471 486	Mayores de edad
T50	LIVB 592 601	Pacientes
#33	AnnotatorNotes T50	C0030705; Patients; Patient or Disabled Group
T51	LIVB 855 864	Pacientes
#34	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	LIVB 944 953	Pacientes
#35	AnnotatorNotes T52	C0030705; Patients; Patient or Disabled Group
T53	LIVB 1071 1116	Mujeres embarazadas o en período de lactancia
#36	AnnotatorNotes T53	C0033011; Pregnant Women; Population Group | C4316174; Patients who are breastfeeding; Patient or Disabled Group
T54	LIVB 1119 1141	mujeres en edad fértil
#37	AnnotatorNotes T54	C4324275; Woman of childbearing potential; Population Group
T56	Neg_cue 1158 1160	no
T45	PHYS 1079 1090	embarazadas
#38	AnnotatorNotes T45	C0032961; Pregnancy; Organism Function
T46	PHYS 1107 1116	lactancia
#39	AnnotatorNotes T46	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T48	Neg_cue 1030 1037	Rechazo
T55	Neg_cue 1040 1052	retirada del
T57	Age 1130 1141	edad fértil
T58	Neg_cue 894 907	diferentes al
T59	PROC 877 893	histológicamente
#40	AnnotatorNotes T59	C0344441; Histology Procedure; Laboratory Procedure
A1	Assertion T28 Negated
A2	Assertion T27 Negated
A3	Population_data T54 Age
A4	Assertion T30 Contraindicated
A5	Assertion T39 Contraindicated
A6	Assertion T33 Contraindicated
A7	Status T36 History_of
A8	Assertion T24 Negated
#41	AnnotatorNotes T41	C5237011; Conductive Chemohyperthermia System; Medical Device (?)
#42	AnnotatorNotes T43	C1522448; Intravesical Route of Drug Administration; Functional Concept
#43	AnnotatorNotes T22	C1278977; Entire upper urinary tract; Body System | C0729865; Upper urinary tract structure; Body Part, Organ, or Organ Component 
#44	AnnotatorNotes T29	C4551691; Urethral stricture; Disease or Syndrome
R1	Used_for Arg1:T1 Arg2:T41	
R2	Has_Route_or_Mode Arg1:T1 Arg2:T43	
R3	Experiences Arg1:T44 Arg2:T2	
R4	Experiences Arg1:T44 Arg2:T41	
R5	Experiences Arg1:T44 Arg2:T3	
R6	Location_of Arg1:T20 Arg2:T3	
T60	Observation 194 205	RIESGO ALTO
R7	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T60	
R8	Location_of Arg1:T34 Arg2:T5	
R9	Location_of Arg1:T7 Arg2:T6	
R10	Experiences Arg1:T47 Arg2:T9	
R11	Experiences Arg1:T47 Arg2:T10	
R12	Location_of Arg1:T11 Arg2:T10	
T61	Observation 441 455	riesgo elevado
R13	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T61	
R14	Location_of Arg1:T13 Arg2:T12	
R15	Experiences Arg1:T50 Arg2:T12	
R16	Experiences Arg1:T50 Arg2:T14	
R17	Causes Arg1:T35 Arg2:T16	
R18	Causes Arg1:T35 Arg2:T15	
A9	Status T16 History_of
A10	Status T15 History_of
R19	Causes Arg1:T17 Arg2:T36	
T62	Quantifier_or_Qualifier 742 748	severa
R20	Has_Quantifier_or_Qualifier Arg1:T36 Arg2:T62	
R21	Location_of Arg1:T19 Arg2:T18	
#45	AnnotatorNotes T18	C2145472; Urothelial Carcinoma; Neoplastic Process
#46	AnnotatorNotes T19	C1519839; Urothelial Cell; Cell
R22	Location_of Arg1:T22 Arg2:T18	
R23	Location_of Arg1:T21 Arg2:T18	
R24	Negation Arg1:T58 Arg2:T24	
R25	Location_of Arg1:T25 Arg2:T24	
R26	Experiences Arg1:T51 Arg2:T23	
R27	Experiences Arg1:T51 Arg2:T24	
R28	Experiences Arg1:T51 Arg2:T59	
#47	AnnotatorNotes T24	C0279680; Transitional cell carcinoma of bladder; Neoplastic Process
R29	Experiences Arg1:T52 Arg2:T26	
R30	Negation Arg1:T55 Arg2:T27	
R31	Negation Arg1:T48 Arg2:T27	
R32	Has_Age Arg1:T54 Arg2:T57	
R33	Negation Arg1:T56 Arg2:T28	
R34	Experiences Arg1:T54 Arg2:T28	
R36	Location_of Arg1:T37 Arg2:T29	
R37	Overlap Arg1:T30 Arg2:T31	
R38	Used_for Arg1:T38 Arg2:T32	
R39	Used_for Arg1:T33 Arg2:T39	
T63	Neg_cue 168 170	NO
T64	Observation 171 190	MÚSCULO INFILTRANTE
A11	Assertion T64 Negated
#48	AnnotatorNotes T64	C4725840; Muscle Invasion; Finding
R40	Negation Arg1:T63 Arg2:T64	
T65	Observation 304 323	Músculo Infiltrante
A12	Assertion T65 Negated
#49	AnnotatorNotes T65	C4725840; Muscle Invasion; Finding
T66	Neg_cue 301 303	No
R41	Negation Arg1:T66 Arg2:T65	
R42	Location_of Arg1:T4 Arg2:T64	
R43	Location_of Arg1:T8 Arg2:T65	
T67	Observation 394 405	infiltrante
A13	Assertion T67 Negated
T68	Neg_cue 391 393	no
R44	Negation Arg1:T68 Arg2:T67	
T69	Observation 612 631	músculo infiltrante
R45	Experiences Arg1:T53 Arg2:T46	
R46	Experiences Arg1:T53 Arg2:T45	
T70	Neg_cue 1189 1191	no
T71	Quantifier_or_Qualifier 1192 1202	hormonales
R47	Negation Arg1:T70 Arg2:T71	
R48	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T71	
#50	AnnotatorNotes T69	C4725840; Muscle Invasion; Finding
A14	Assertion T71 Negated
R49	Location_of Arg1:T13 Arg2:T69	
#51	AnnotatorNotes T60	C4319571; High risk; Finding
#52	AnnotatorNotes T61	C4319571; High risk; Finding
#53	AnnotatorNotes T62	C1547227; Severe - Severity of Illness Code; Intellectual Product
#54	AnnotatorNotes T71	C0458083; Hormonal; Qualitative Concept
#55	AnnotatorNotes T3	C1336527; Non-Muscle Invasive Bladder Neoplasms; Neoplastic Process
#56	AnnotatorNotes T6	C1336527; Non-Muscle Invasive Bladder Neoplasms; Neoplastic Process
#57	AnnotatorNotes T10	C1336527; Non-Muscle Invasive Bladder Neoplasms; Neoplastic Process
#58	AnnotatorNotes T12	C4725841; Muscle Invasive Bladder Carcinoma; Neoplastic Process
A15	Experiencer T44 Patient
A16	Experiencer T47 Patient
A17	Experiencer T50 Patient
A18	Experiencer T51 Patient
A19	Experiencer T52 Patient
A20	Experiencer T53 Patient
A21	Experiencer T54 Patient
